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Abstract
Introduction: Lineage tracing studies in mice have revealed the localization and existence of lineage-restricted
mammary epithelial progenitor cells that functionally contribute to expansive growth during puberty and differentiation
during pregnancy. However, extensive anatomical differences between mouse and human mammary tissues preclude
the direct translation of rodent findings to the human breast. Therefore, here we characterize the mammary progenitor
cell hierarchy and identify the anatomic location of progenitor cells within human breast tissues.
Methods: Mammary epithelial cells (MECs) were isolated from disease-free reduction mammoplasty tissues and assayed
for stem/progenitor activity in vitro and in vivo. MECs were sorted and evaluated for growth on collagen and expression
of lineages markers. Breast lobules were microdissected and individually characterized based on lineage markers
and steroid receptor expression to identify the anatomic location of progenitor cells. Spanning-tree progression
analysis of density-normalized events (SPADE) was used to identify the cellular hierarchy of MECs within lobules
from high-dimensional cytometry data.
Results: Integrating multiple assays for progenitor activity, we identified the presence of luminal alveolar and basal
ductal progenitors. Further, we show that Type I lobules of the human breast were the least mature, demonstrating an
unrestricted pattern of expression of luminal and basal lineage markers. Consistent with this, SPADE analysis revealed
that immature lobules were enriched for basal progenitor cells, while mature lobules consisted of increased hierarchal
complexity of cells within the luminal lineages.
Conclusions: These results reveal underlying differences in the human breast epithelial hierarchy and suggest that
with increasing glandular maturity, the epithelial hierarchy also becomes more complex.
Introduction
The breast undergoes dynamic changes over the lifetime
of a woman, from initial development at puberty, to prolif-
eration and apoptosis during the menstrual cycle in re-
sponse to hormonal fluctuations, and culminating with
full lobuloalveolar development for lactation. Studies from
murine mammary glands have demonstrated the presence
of an epithelial hierarchy that serves to prevent exhaustion
of progenitors necessary for tissue homeostasis and glan-
dular regeneration. These extensive studies have identified
and localized lineage-restricted progenitor cells that
can be assayed using both in vitro and in vivo tech-
niques (for review [1-4]).
There are numerous differences between the human
breast and the mouse mammary gland that preclude the
direct translation of rodent studies to human breast devel-
opment. The human breast is composed of 11 to 48 central
ducts that radiate outward from the nipple [5], where
circulating hormones and localized growth factors likely
coordinate the growth of the terminal ductal lobular units
(TDLU) that emanate from primary ducts. Each lobe is or-
ganized as heterogeneous lobular structures, each one
representing a sequential developmental stage [6-8]. In
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ple ductal tree that lack TDLU, and only exhibit strain-
specific rudimentary alveolar budding in the absence
of pregnancy. Thus, the anatomical and physiological
equivalency of lobules and TDLU is unclear in the
mouse.
The mammary gland is composed of a bi-layered epi-
thelium; basal/myoepithelial (ME) cells express cytoke-
ratin (CK) 14 surrounding a luminal layer that stains
positively for CK8/18. In the mouse, CK expression is
specific for each epithelial layer, which has enabled the
use of these markers for lineage tracing studies to estab-
lish the presence of lineage-restricted progenitor cells
within each layer of the mammary epithelium [9]. Unlike
the mouse, little is known about the identity and dynam-
ics of progenitor cells in the human breast, and details
about their activity and the mechanisms that regulate
their numbers and differentiation remain poorly under-
stood. Interestingly, contiguous regions of human breast
lobules contain cells showing identical X-chromosome
inactivation patterns suggesting that they were likely de-
rived from a common uncommitted stem cell [10].
The limited understanding of human breast develop-
ment and stem cell biology has largely been due to the
lack of appropriate model systems and assays to detect,
analyze, and characterize stem cell properties. In recent
years, we and others have developed and optimized various
in vivo and in vitro tools to study the biology and mecha-
nisms governing human breast development [1,11-16].
Using these approaches we sought to dissect the epithelial
hierarchy of the human breast and identify the anatomic
locations of progenitor cells within the breast. In doing
so, we reveal that human breast tissues contain two
types of phenotypically distinguishable progenitor cells
localized to the luminal and basal lineages, respectively,
which contribute to different anatomical structures.
Further, we show that immature lobules within the breast
harbor distinct types of progenitor cells.
Materials and methods
Animal studies
All animal procedures in this study were approved by
the Tufts University Institutional Animal Care and Use
Committee (IACUC), and all animal procedures were
conducted in accordance with this approved protocol.
Colonies of NOD/SCID mice were maintained in house.
Mice were given food and water ad libitum.
Primary tissue isolation and culture
All human breast tissues were obtained in compliance
with the laws and institutional guidelines, as approved by
the Institutional Review Boards (IRB) from Tufts Medical
Center and Beth Israel Deaconess Medical Center. For
these studies, we utilized de-identified, non-cancerous
breast tissues from patients undergoing elective reduc-
tion mammoplasty surgery under the Category 4 exemp-
tion of the IRB Review. As de-identified patient samples
were utilized for this study, patient consent was not re-
quired. The tissue was sampled to make whole mounts
and paraffin blocks, and snap frozen for molecular ana-
lyses, and the remainder was enzymatically digested to
epithelial organoids as previously described [12,17]. The
epithelial organoids were aliquoted in 1:1 DMEM/Hams-
F12 media (Invitrogen, Grand Island, NY USA) supple-
mented with 5% calf serum, 10 ng/mL insulin, 10 μg/mL
epidermal growth factor (EGF), 10 μg/mL hydrocorti-
sone, and 10% dimethyl sulfoxide (DMSO) and stored
in liquid nitrogen for later use Insulin, hydrocortisone,
EGF, and DMSO were all obtained from Sigma-Aldrich
Corporation (St. Louis, MO, USA). To humanize mice,
mammary epithelium was removed from the fourth
mammary glands of 3-week-old NOD/SCID females, and
RMF-EG cells were injected into the fat pad as described
[12]. Two weeks post-humanization, epithelial organoids
were dissociated to single cells (100,000 cells), co-mixed
with primary breast stromal cells (2.5 ×10
5 cells per
gland) in a 1:1 mixture of collagen and Matrigel (BD
Biosciences, San Jose, CA, USA) and injected into
humanized fat pads. RMF-EG cells and primary breast
stromal cells were grown in high glucose DMEM
(Invitrogen) supplemented with 10% calf serum and 1%
penicillin/streptomycin at 37°C and 5% carbon dioxide.
Progenitor cell assays
For colony formation, 40,000 human mammary epithelial
cells (MEC) were plated on non-adherent plates or adher-
ent plates in 2 mL of epithelial basal media supplemented
with bovine pituitary extract (52 μg/mL), hydrocortisone
(0.5 μg/mL), human EGF (10 ng/mL), and insulin (5 μg/mL;
Lonza, Allendale, NJ, USA) for 7 days. Mammospheres or
floating colonies were plated in triplicate and quantified
using a Multisizer3 Coulter Counter (Beckman Coulter,
Danvers, MA, USA). Colonies growing on adherent
plates were fixed with methanol and stored at −20°C
until stained for cytokeratins 8 and 14. Mammospheres
and floating colonies were cytospun onto glass slides,
methanol fixed, and stored at −20°C until used for ana-
lyses. For growth on collagen, 1 mg/mL rat tail collagen
(pH = 7; BD Biosciences) polymerized for 30 minutes at
37°C on four- or eight-well chamber slides (Corning,
Corning, NY, USA). MECs (n = 5,000) were plated in
1 mL of complete epithelial basal media supplemented
with 2% Matrigel (BD Biosciences) in duplicate. Colony
growth was observed using Nikon Eclipse Ti and quanti-
fied based on morphology. For mammosphere and float-
ing colony growth on collagen, MECs were grown as
mammospheres and floating colonies for 7 days in tripli-
cate. One replicate was quantified, and two replicates were
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in duplicate.
Mammary whole mounts
Tissue isolated from elective reduction mammoplasty sur-
gery from eight patients was used to make whole mounts.
Each tissue was sampled in 5 to 10 different areas to make
whole mounts, which were formalin-fixed overnight and
stained with carmine. The tissue was sliced into 2- to
3-mm sections, dehydrated in graded alcohols, and incu-
bated in xylenes to remove fat. The mammary sections
were imaged using a Nikon Eclipse80i microscope, and
lobules were identified as described [6]. Briefly, the num-
ber of ductules/lobule were counted and categorized as
Type I (average (avg) 11 ductules/lobule), Type II (avg 47
ductules/lobule), and Type III (avg 81 ductules/lobule).
Lobules of each type were quantified from multiple
sections of the reduction mammoplasty tissue, bluntly dis-
sected with a razor, paraffin-embedded, and sectioned at
5 μm for immunohistochemical and immunofluorescent
staining.
Immunofluorescence and immunohistochemistry
Human-in-mouse normal outgrowth tissue sections were
stained with an antibody for α-smooth muscle actin
(1:1000; Vector Laboratories, Burlingame, CA, USA).
Sorted breast lobules and sections from human-in-mouse
normal outgrowths were stained with antibodies for cyto-
keratin (CK) 8/18 (1:250, Vector Laboratories) and CK 14
(1:250, Thermo Scientific, Tewksbury, MA, USA). Breast
lobules were additionally stained with p63 (1:500; Santa
Cruz Biotechnologies, Dallas, TX, USA), estrogen receptor
alpha (1:500, F10 clone, Santa Cruz Biotechnologies), pro-
gesterone receptor (1:250; Cell Signaling Technologies,
Danvers, MA, USA), and EpCAM (1:500; Stem Cell
Technologies, Vancouver, BC, Canada).
For immunohistochemistry, tissue sections were incu-
bated with 2% hydrogen peroxide to quench endogenous
peroxidase, antigen retrieved in 0.1 M citrate (pH = 6.0),
and blocked with 1% BSA and 1.5% goat serum in PBS for
1 hour. Tissue sections were incubated with primary anti-
bodies in 1% BSA in PBS overnight at 4°C, followed by
secondary antibodies for 30 minutes at room temperature
(1:250 biotinylated anti-mouse or anti-rabbit; Vector
Laboratories). Staining was detected using Vectastain ABC
kit followed by ImmPact DAB kit (Vector Laboratories),
and sections were counterstained using hematoxylin. For
adherent colonies on plastic plates, colonies were fixed in
methanol at −20°C for 10 minutes, and cells were perme-
abilized with 0.1% triton in PBS for 10 minutes. Cells were
blocked with 1% bovine serum albumin (BSA) and 1.5%
goat serum in PBS for 1 hour, incubated with anti-rabbit
CK 14 at 4°C overnight, and stain was detected as de-
scribed above. Following 3,3-diaminobenzidine (DAB)
stain, colonies were blocked with the avidin/biotin blocking
kit (Vector Laboratories) per the manufacturers’ instruc-
tions, with 1% BSA in PBS for 1 hour, and with anti-mouse
CK 8/18 overnight. Specific staining was detected as de-
scribed above, except the substrate used for detection was
the VIP kit (Vector Laboratories). Colonies were air-dried
and quantified by morphology and cytokeratin expression
as described [16].
For immunofluorescence, tissue sections were antigen-
retrieved in 0.1 M citrate (pH = 6.0) and blocked with 1%
BSA and 1.5% goat serum in PBS for 1 hour. Tissue sec-
tions were incubated with primary antibodies in 1% BSA
in PBS overnight at 4°C, followed by secondary antibodies,
for 30 minutes at room temperature (1:250; Alexa Fluor
488 or 546, Invitrogen). Nuclei were counterstained with
4′,6-diamidino-2-phenylindole (DAPI) in the mounting
media using Vectashield (Vector Laboratories). For
double-labeling, tissue sections or mammospheres and
floating colonies were incubated with rabbit primary anti-
bodies and secondary antibodies followed by mouse pri-
mary and secondary antibodies. Images were captured
with Nikon Eclipse 80i and merged using ImageJ software.
Quantification of mammary whole-mount staining
Five lobules of each type were evaluated from each patient
sample. The percentage of positive cells for each marker
was quantified in each high-power image and categorized
into one of three percentage categories. EpCAM staining
was evaluated using Allred scoring based on staining in-
tensity and number of cells staining positively. Staining
differences among lobule types was determined by chi-
squared analyses.
Flow cytometry
Unsorted cells from organoid preparations were dissociated
to a single-cell suspension as described above and filtered
through a 20 μm nylon mesh (EMD, Millipore,
Billerica, MA, USA). Endothelial, lymphocytic, mono-
cytic, and fibroblastic lineages were depleted with anti-
bodies to CD31, CD34, and CD45 (all from Thermo
Scientific), fibroblast-specific protein IB10 (Sigma), and a
mixture of pan-mouse IgG and IgM Dynabeads (Dynal;
Invitrogen) according to the manufacturers’ instructions
and as described previously [11,18]. Lineage-depleted
single-cell suspensions or cells from immunomagnetic
bead-sorted populations were resuspended at 1×10
6 cells
per mL in PBS containing 1% calf serum (fluorescence-
activated cell sorting (FACS) buffer) and bound with
fluorescently conjugated antibodies to human EpCAM
(allophycocyanin), CD24 (FITC; BD Biosciences), CD49f
(PerCP-Cy5.5; Biolegend, San Diego, CA, USA), and CD10
(phycoerythrin; Dako, Carpenteria, CA, USA) for 20 mi-
nutes at 4°C. Antibody-bound cells were washed and
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6 cells per mL in FACS buffer and
run on a FACSCalibur flow cytometer (BD Biosciences).
Flow cytometry data were analyzed with the FlowJo
software package (TreeStar, Ashland, OR, USA). Cellu-
lar debris and dead cells removed from analysis through
manual gating and use of propidium iodide. Gates were
set on the remaining cells based on isotype controls for
each antibody.
Spanning-tree progression analysis of density-normalized
events (SPADE)
SPADE was used to generate tree diagrams from flow
cytometry data as previously described [19] using the
SPADE 2.0 MATLAB implementation. Enzymatically
dissociated, lineage-depleted breast-reduction tissue was
prepared and analyzed by flow cytometry. Ungated FACS
data generated from eight patient samples was used
to construct the SPADE tree using three parameters
(CD49f, CD24, and EpCAM). Downsampling was
manually set at 10,000 cells per sample and the number
of desired clusters set to 50. The SPADE tree generated
was evaluated and sectioned based on characterized rela-
tionships between markers: mature luminal (EpCAM
hiCD
49f
−), luminal progenitor cells (LPC) (EpCAM
hiCD49f
+),
mature basal (MB) (EpCAM
loCD49f
+), basal progenitor
cells (BPC) (EpCAM
−CD49f
+), and mammary lineage
negative (MLN) (EpCAM
−CD49f
+). To visualize differ-
ences between tissue samples predominantly consist-
ing of immature (Type I/II) and mature (Type III)
lobules, data from four patients enriched for Type I/II
lobules and 4 patients enriched for Type III lobules
were concatenated in FlowJo, upsampled to the
previously generated SPADE tree, and pseudocolored
to indicate differences in the frequency of cells falling
into each cluster.
Bead sorting
MEC were plated briefly in serum (1 to 2 h) to deplete
mammary fibroblasts from the organoid fraction. The orga-
noids remaining in suspension were dissociated by trypsini-
zation and filtered with a 40 μm filter (BD Biosciences) to
remove residual clustered cells. Single-cell suspensions of
breast epithelial cells were sorted with CELLection pan-
mouse IgG magnetic beads (Dynal; Invitrogen) conjugated
to an anti-CD10 antibody (clone SS2/36; Santa Cruz
Biotechnology) according to the manufacturer’s instruc-
tions. CD10
+ cells were released from the beads by DNase
treatment with occasional agitation at 37°C for 10 minutes.
Cells that did not bind to the CD10 beads were further
sorted with magnetic beads conjugated to an anti-EpCAM
antibody (clone VU-ID9; Abcam, Cambridge, MA, USA
and AbD Serotec, Raleigh, NC, USA). Positive cells were
again released by DNase treatment. EpCAM
+ bead-sorted
cells were further sorted by binding of CD49f antibody
(clone 450–30A; AbD Serotec) followed by binding of pan-
mouse IgG CELLection beads. Beads were released from
positively sorted cells as described above. Viable cells
(verified by trypan blue exclusion) from unsorted, basal
progenitor cells (BPC, EpCAM
−CD10
+), mature basal
(MB; EpCAM
+/loCD10
+), luminal progenitor cells (LPC,
EpCAM
+CD49f
+) and mature luminal (ML) (EpCAM
+CD49f
−) cells were used for collagen assays.
Statistics
Differences between two groups were detected with
Student’s t-test, and differences among multiple groups
were detected using repeated measures analysis of vari-
ance (ANOVA) with multiple comparisons post hoc
test. Statistical analyses were performed using Graph
Pad Prism software (La Jolla, CA, USA).
Results
Heterogeneity in human breast epithelial cell lineages
In humans, the surface antigen markers EpCAM and
CD49f have been used to define MEC populations within
the luminal and basal lineages [11,20-22]. Specifically,
cells with an EpCAM
+hi/CD49f
neg,E p C A M
+hi/CD49f
+,
EpCAM
+lo/CD49f
+, and EpCAM
neg/CD49f
+ immunophe-
notype are enriched for ML, LPC, MB, and BPC, respect-
ively (Figure 1A). Similarly, the cell surface marker CD10/
CALLA is expressed by basal/myoepithelial (MB) cell
populations (Figure 1A); [11,23-26]. Using these markers,
we performed flow cytometry on lineage depleted epithe-
lial cells isolated from tissue generated from elective re-
duction mammoplasty surgery (n = 15 patient samples,
characterized in Additional file 1: Table S1), and we quan-
tified the ML, LPC, MB, and BPC populations. Significant
heterogeneity in the percentage of ML, LPC, MB, and
BPC populations was observed in the normal breast tissue
across all patient samples (Figure 1B, Additional file 1:
Table S1 and Table S2) and was not correlated with age
or parity.
To characterize the ML, LPC, MB, and BPC popula-
tions, MEC were sorted based on EpCAM and CD49f
expression and assessed for luminal and basal lineage
markers (CK8 and CK14, respectively). Although all
EpCAM
hi cells expressed abundant CK8, MLs and LPCs
also contained sub-populations that co-expressed both
CK8 and CK14 markers (Figure 1C). Similarly, while the
majority of sorted MB and BPC lacked CK8 expression,
there was a sub-population of EpCAM
lo/neg/CD49f
+
cells that co-expressed both CK8 and CK14 markers
(Figure 1C). These results suggest that CK8 expression
is not exclusively restricted to the luminal lineages in
human MEC.
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tissues
Although flow cytometry studies have identified epithelial
populations that correspond to distinct lineages within the
epithelial hierarchy, they do not directly quantify progeni-
tor activities. In vitro and in vivo assays have been estab-
lished to quantify progenitor numbers and to assess
functional activity of dissociated MECs isolated from
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Figure 1 Cell surface markers define cell populations that are variable among patient-derived epithelial cells. (A) Representative flow
cytometry plots demonstrating defined epithelial cell populations using the cell surface markers EpCAM, CD10 and CD49f. ML= mature luminal,
LPC= luminal progenitor cells, MB= mature basal, and BPC=basal progenitor cells. Epithelial cells were isolated from breast tissue from patients
undergoing elective reduction mammoplasty surgery. (B) Percentage of epithelial cells in each cell population for 15 patient samples. (C) Epithelial
cells were sorted from primary breast tissue using cell surface markers EpCAM and CD49f and stained for cytokeratin 8 (CK8) and CK14. ML and LPC
populations were enriched for CK8
+ epithelial cells, and MB and BPC were enriched for CK14
+ cells.
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density under non-adherent culture conditions, MECs
formed mammospheres that were enriched for bi-potent
CK8/14
+ (Figure 2A; [27]) cells, suggesting that both
luminal and basal lineages of cells were enriched.
Mammosphere progenitor frequency was 6.7/1000 cells
when quantified in 19 MEC samples (Table 1, Additional
file 1: Table S3). In contrast, when grown on adherent
plates, luminal MEC preferentially floated in suspension
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Figure 2 Epithelial cell growth in suspension enriched for progenitors in different lineages. (A) Colonies from epithelial cells that grew in
suspension in non-adherent culture (mammospheres) expressed both cytokeratin 8 (CK8
+; luminal) and CK14 (basal). Colonies that grew in
suspension over adherent plates (floating colonies) were CK8
+ but were negative for CK14. (B) Epithelial cells formed characteristic colonies on
adherent plates that were CK8
+, CK14
+, or CK8/14
+ (bi-potent). (C) When grown on adherent plates, CD10
+ cell populations formed bi-potent
and basal colonies, while EpCAM
+ cell populations formed bi-potent and luminal colonies. Epithelial cells were sorted based on cell surface
markers EpCAM and CD10, grown in adherent culture, stained for CK8/14, and colonies were quantified. Scale bar = 100 μm.
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ing that these floating colonies are enriched for luminal
progenitor activity. The frequency of luminal progenitor
growth was 4.8/1000 cells (n = 18 MEC samples; Table 1,
Additional file 1: Table S3).
While a population of luminal progenitor cells formed
floating colonies, primary MEC also formed adherent
colonies enriched for luminal (CK8
+), basal (CK14
+), or
bipotent cells (CK8/14
+; Figure 2B, [11,16]). There was
significant patient heterogeneity in the predominant col-
ony type that grew on plastic. Luminal and basal col-
onies formed the most frequently, 3.6/1000 and 2.9/1000
cells respectively (n = 19 MEC samples; Table 1, Additional
file 1: Table S3), while mixed-lineage colonies occurred at a
lower frequency (2/1000 cells).
To determine how this colony-forming ability related
to the ML, LPC, MB, and BPC populations delineated
by flow cytometry, MEC were sorted for EpCAM and
CD10 expression and grown on adherent plates to
examine lineage markers of the resulting colonies (lu-
minal CK8 and basal CK14). Sorted luminal (EpCAM
+)
cells rarely attached to adherent plates, but when they
did, they formed colonies enriched in luminal and bi-
potent cells (Figure 2C). While basal cells (CD10
+) read-
ily formed colonies, they formed colonies enriched for
basal as well as bi-potent cells (Figure 2C). These results
suggest that CK8/14 bi-potent progenitor cells are
present within both luminal and basal epithelial lineages
of the human breast.
Structural progenitor activity is present in luminal and
basal lineages
In order to examine human MEC growth in vivo,w ed i s -
sociated MEC and implanted them into humanized
mammary fat pads of NOD/SCID mice. Dissociated
MEC demonstrated the ability to form bi-layered ductal
or alveolar structures (Figure 3A), that were positive for
CK18 in the luminal layer as well as smooth muscle
actin (SMA), which is expressed by myoepithelial cells
(Figure 3A). In vitro, single MECs grown at clonal dens-
ity also formed distinct ductal and alveolar colonies
(Figure 3B), when grown on a Type I collagen substrate
three-dimensionally. The frequency of these structural
progenitors was quantified from dissociated MEC from
13 patient samples (Figure 3B, Table 1).
To assess which types of structural progenitors were
enriched within sorted MEC populations, ML, LPC, MB,
and BPC were sorted based on EpCAM and CD10 ex-
pression and were grown at clonal density on collagen.
Sorted ML and LPC populations were enriched in alveo-
lar progenitors, while BPC were the major source of
ductal progenitors (Figure 3C), consistent with recent
findings [11]. These results suggest that both ML and
LPC populations are enriched for alveolar progenitor
cells, while the BPC population is the major source for
ductal progenitor cells.
In order to evaluate the relationship between luminal
and basal progenitors and structural progenitors, we
grew primary MECs for 7 days in non-adherent cultures
(mammospheres) or in suspension above adherent plates
(floating colonies) and then quantified and plated the
colonies on collagen gels (Figure 3D). Growth as mam-
mospheres significantly enriched both alveolar (85-fold)
and ductal progenitor cells (275-fold) compared with
growth as single cells on collagen. In contrast, growth as
floating colonies only significantly enriched alveolar pro-
genitor cells (140-fold). Together, these results suggest
that growth of MEC as mammospheres enriches for
both luminal alveolar and basal ductal progenitor activ-
ity, while growth as floating colonies preferentially en-
riches for luminal alveolar progenitor activity.
In situ localization of lineage restricted and unrestricted
cells within lobules
Although human breast stem/progenitor cells have been
proposed to exist within both main ducts and TDLU, it
is unclear in which ducts and TDLU these progenitor
cells actually reside. Human breast lobules have previ-
ously been categorized as Type I, Type II, Type III, and
Type IV based on the complexity of the ductule/lobule
Table 1 Summary of frequency of progenitor activity
Uncultured cells
Progenitor type Progenitor
lineage
mean± sd Frequency,
number/1000 cells
Adherent
progenitors
(n = 19)
Total Both 0.0098±0.0023 9.8/1000
Bi-potent Both 0.002± 0.0014 2/1000
Luminal
progenitors
Luminal 0.0036±0.004 3.6/1000
Basal progenitors Basal 0.0029±0.004 2.9/1000
Non-adherent
progenitors
Mammospheres
(n = 19)
Both 0.0067±0.00092 6.7/1000
Floating colonies
(n = 18)
Luminal 0.0048±0.00088 4.8/1000
Structural
progenitors
(n = 13)
Total 0.003± 0.0006 3/1000
Luminal alveolar
progenitor
Luminal 0.002± 0.003 2/1000
Basal ductal
progenitor
Basal 0.0009±0.0004 0.9/1000
Average age 34.5 ± 12.6 yrs (mean± SD).
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http://breast-cancer-research.com/content/16/5/453formation. Type I lobules are the least developed, having
the smallest number of ductules/lobules, while Type IV
are the most developed and are only present in the
breast during pregnancy and lactation [6,8]. To deter-
mine whether each of the lobule types might represent
anatomical structures that harbor different types of pro-
genitor cells, we microdissected lobules from human
breast reduction mammoplasty samples from women
from ages 18 to 50 years and quantified the different
types of lobules in each patient sample, according to the
previously described system [6]. As expected, there was
considerable heterogeneity among patient samples in the
number of Type I, Type II and Type III lobules present
in any given breast tissue (Figure 4A, B). In contrast to
previous reports [8], there was no correlation between
the number and types of lobules and age; when averaged
across all breast tissue, Type I, Type II and Type III lob-
ules represented about 1/3 of the structures (Figure 4B).
Interestingly, patients number 4 and 6 demonstrated
increased numbers of Type III lobules (Figure 4B),
although both patients were nulliparous (Additional file
1: Table S1). In contrast, patient 13 had fewer Type III
lobules following three pregnancies (Figure 4B, Additional
file 1: Table S1).
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Figure 3 Alveolar progenitors are enriched in luminal cell populations, while ductal progenitors are enriched in basal cell populations.
(A) In vivo, primary epithelial cells isolated from reduction mammoplasty tissue form bilayered ductal or alveolar structures when grown in the
humanized fat pads of NOD/SCID mice. These structures expressed luminal cytokeratin 18 (CK18) and basal smooth muscle actin (SMA). (B) In
vitro, primary epithelial cells formed either ductal or alveolar structures when grown on collagen gels (n = 12; mean± standard error of the mean
(SEM)). (C) Ductal progenitor activity was enriched in the basal progenitor cell (BPC) population, while alveolar progenitor activity was enriched in
mature luminal (ML) or luminal progenitor cell (LPC) populations. Epithelial cells were sorted using cell surface markers CD10 and EpCAM and
grown on collagen gels. Differences were detected using analysis of variance (n = 3; mean± SD). (D) Growth in suspension as mammospheres
enriched for both alveolar and ductal progenitor activity, while growth in suspension as floating colonies over adherent plates enriched for
alveolar progenitor activity. Epithelial cells were grown in suspension as floating colonies and mammospheres for 7 days then plated on collagen
gels. Ductal and alveolar progenitor activity was quantified (n = 12; mean±SEM). Scale bar = 100 μm. MB, mature basal.
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Figure 4 (See legend on next page.)
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http://breast-cancer-research.com/content/16/5/453Given that the lobules are thought to undergo succes-
sive maturation [6,8], we examined markers to assess the
maturity of each lobule type. Type I lobules demonstrated
the most variability with respect to CK8 and CK14 expres-
sion; in 11% of Type I lobules <10% of cells stained posi-
tive for CK8 expression while this was rarely observed in
Type II and Type III lobules. In addition, in 28% of Type I
lobules >50% of cells stained positive for CK14 while such
high levels of CK14 expression were not found in Type II
and Type III lobules (Figure 4C, D). Furthermore, unlike
the murine mammary gland [9], CK8 and CK14 expres-
sion was not always restricted to the luminal and basal
layers of the epithelium, respectively, while p63, a well-
characterized marker of basal epithelial cells, exhibited
restricted basal cell expression within all of the lobules
examined (Figure 4F). In Type I lobules, basal cells
expressed CK8 and luminal cells expressed CK14. In
fact, nearly 40% of Type I lobules demonstrated luminal
CK14 expression, and epithelial cells were identified
that co-expressed CK8 and CK14 (Figure 4C, E). In
addition, unlike Type II and Type III lobules, Type I lob-
ules exhibited a more heterogeneous distribution of CK
expression. While Type II and III lobules were signifi-
cantly enriched in luminal CK8
+ cells they contained
fewer basal CK14
+ cells. Moreover, the epithelial cells
within Type II and Type III cells showed a predominant
linage-restricted expression pattern of luminal and basal
markers (Figure 4C, D). These results suggest that Type
I lobules are enriched for fewer lineage-restricted pro-
genitor breast epithelial cells and contain more CK14
+
and CK8
+ epithelial cells.
Type I lobules demonstrate reduced expression of
luminal markers
Given the difference in CK8/14 expression in Type I
lobules compared to Type III lobules, we examined other
markers associated with differentiation. Type I lobules
have been reported to exhibit the highest percentage of es-
trogen receptor (ER) α and progesterone receptor (PR)
positive [6,28], as well as the highest proliferative index
[7,28]. Similar to the expression of CK8 and CK14, Type I
lobules demonstrated significantly greater variability than
Type II or Type III lobules for ERα and PR expression
(Figure 5A). Consistent with previous reports [28], a
higher proportion of the Type I lobules exhibited >20%
cells expressing ERα and PR compared to the other lobule
types (Figure 5A). We also assessed proliferation utilizing
the marker Ki67. Although Ki67 expression was variable
within the Type I lobule group, unlike ERα and PR ex-
pression, there were no significant differences among
lobule types (Figure 5A). These results demonstrate
significant heterogeneity within Type I lobules for
multiple markers.
As Type I lobules demonstrated significant variations
in ERα and PR expression as well as differences in CK8
and CK14 localization, we examined the expression of
EpCAM. We quantified both the expression and inten-
sity of EpCAM stain using the Allred scoring system
(Figure 5B). Similar to the other markers examined, Type
I lobules demonstrated variable staining with EpCAM,
with some lobules enriched for an EpCAM
lo/neg popula-
tion of epithelial cells (Figure 5B). Although a population
of Type I lobules demonstrated EpCAM
lo/neg staining,
these lobules still expressed PR, suggesting luminal rather
than basal differentiation (Figure 5B). In total, these re-
sults suggest that epithelial cell within Type I lobules
are less differentiated and enriched for progenitor popu-
lations. In addition, these findings suggest that Type III
lobules are more mature, harboring more differentiated
and lineage-committed epithelial cells.
Complexity of the epithelial hierarchy trees defines lobule
types
A major difficulty in delineating the epithelial hierarchy
of the human breast has been the inability to equate
progenitor populations defined ex vivo using cell surface
immunophenotypes with their in vivo counterparts. As
Type I lobules were enriched in less differentiated lu-
minal and basal epithelial cells and Type III lobules were
enriched in more mature lineage committed cells, we
speculated that the proportion of ML, LPC, MB, and
BPC might correlate with specific lobule types. Although
we observed significant histological differences in CK8/
14 expression patterning and EpCAM expression levels
in Type I and Type III lobules, there was no single or
combinatorial population of EpCAM/CD49f cells that
(See figure on previous page.)
Figure 4 Type I lobules demonstrated variable cytokeratin 8 (CK8) and CK14 expression. (A, B) Type I, Type II, and Type III lobules were
(A) identified and microdissected from reduction mammoplasty tissue, then (B) quantified in each tissue sample (n = 8). (C, D) No significant
differences were detected in the percentage of cells expressing CK8 and CK14 among lobule types. Type I-III lobules were stained for CK8 and
CK14 and characterized for the percent positive cells in each lobule. The number of individual lobules in each category was quantified for each
lobule type (n = 15 lobules/patient). (E) Type I lobules demonstrated significantly increased expression of basal CK8 and luminal CK14 compared to
other lobule types. Type I-III lobules were characterized for expression of CK8 and CK14 in the luminal and basal layer, and the number of individual
l o b u l e si ne a c hc a t e g o r yw a sq u a n t i f i e df o re a c hl o b u l et y p e( n=1 5l o b u les/patient). Statistical differences were detected by chi squared
analysis. (F) p63 was expressed exclusively in the basal layer in all lobules types examined. Type I-III lobules were characterized for the
percentage of cells in the basal layer that expressed p63. The number of individual lobules in each category was quantified for each lobule
type (n = 15 lobules/patient). Scale bar = 100 μm.
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http://breast-cancer-research.com/content/16/5/453correlated with any lobule distribution using standard
flow cytometry analysis (Figure 6A, Additional file 1:
Table S2).
A recent study has suggested that traditional data ana-
lyses for flow cytometry may obscure the underlying
continuity of phenotypes that is inherent in cellular dif-
ferentiation [29]. In order to further explore the relation-
ship between lobule types and the epithelial hierarchy of
the breast, we utilized a recently reported computational
approach to objectively organize our flow cytometery
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Figure 5 Type I lobules are enriched for basal progenitor cells. (A) Type I lobules demonstrated significantly different patterns of estrogen
receptor (ER)α and progesterone receptor (PR) expression compared with other lobule types. Lobules were stained for ERα, PR, and Ki67, and the
number of individual lobules in each category was quantified for each lobule type (n = 15 lobules/patient). Statistical differences were detected
by chi-squared analysis. (B) Type I lobules demonstrated significantly reduced levels of EpCAM expression compared with other lobule types.
Lobules were stained for EpCAM, and scored for cellular expression and intensity using Allred scoring criteria. The number of individual lobules in
each category was quantified for each lobule type (n = 15 lobules/patient). Statistical differences detected by chi-squared analysis. Scale
bar = 100 μm.
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http://breast-cancer-research.com/content/16/5/453data into a hierarchy of related phenotypes [19]. SPADE
extracts a hierarchy from high-dimensional cytometry
data in an unsupervised manner, which enables multiple
cell types to be visualized in a branched tree structure in
an unbiased manner [19]. Based on the local density of
cell surface markers, SPADE mathematically reduces the
number of cells represented in high-density regions,
while maintaining the density of populations of rare cell
types or cells in transition between the abundant cell
types. Next, SPADE clusters each single cell with other
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Figure 6 Hierarchal trees reveal differences in the cellular hierarchy of Type I/Type II and Type III lobules. (A) No correlations were found
among specific cell populations, lobule type, or patient age. Percentage of epithelial cells in mature luminal (ML), luminal progenitor cell (LPC),
mature basal (MB), and basal progenitor cell (BPC) populations assessed by flow cytometry analysis were compared to the percentage of each
type of lobule found within the breast tissue for each patient sample (n = 8). (B) Spanning-tree progression analysis of density-normalized events
(SPADE) was performed on flow cytometry data for protein markers EpCAM, CD24, and CD49f from eight patient samples with characterized lobule
composition. Node size reflects the median number of cells in each population across the heterogeneous population. Dashed lines represent cell
populations delineated by cell surface marker profiles. (C) The cell frequencies from breast samples with enrichment for Type I/Type II and Type
III lobules were separated and visualized across the SPADE-derived tree. Nodes are colored by the median intensities of cell numbers in each
node. Dashed lines represent cell populations delineated by cell surface marker profiles. (D, E) SPADE was performed on flow cytometry data for
EpCAM, CD24, and CD49f for breast samples enriched for Type I/Type II (D) and Type III (E) lobules (n = 4 samples each). Dashed lines represent cell
populations delineated by cell surface marker profiles. MLN, mammary lineage negative.
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http://breast-cancer-research.com/content/16/5/453cells based on the density of their cell surface markers
and assigns each cell in the original data set to the gen-
erated clusters. The nodes generated by the SPADE ana-
lyses are of varying size, based on the number of cells
represented within the node, and are colored by the me-
dian intensities of the cell surface markers represented
by cells within that node.
SPADE was used to generate a hierarchal tree based
on the eight reduction mammoplasty tissue samples that
had been characterized by both flow cytometry and lob-
ule composition (Figure 6B). Following SPADE, we ex-
amined the colored trees to manually identify the ML,
LPC, MB or BPC populations represented by each part
of the tree based on their known cell surface markers
(Additional file 1: Figure S2A). We then determined the
contribution of individual cell frequencies from less ma-
ture (Type I/Type II) and mature (Type III) lobules to the
nodes comprising each defined population within the hier-
archal tree (Figure 6C). Breasts with increased numbers of
Type I/Type II lobules demonstrated a higher frequency
of cells within the basal lineages as well as a group that
was MLN (negative for EpCAM, CD24, CD49f), while
those containing more Type III lobules were enriched
in cells that were positive for luminal lineage markers
(Figure 6C). These results demonstrate for the first
time in the human breast a clear relationship between
progenitor populations identified at the cellular level
and structural features identified at the tissue level.
Specifically, they suggest that differences in the cellular
hierarchy exist between tissues predominantly consist-
ing of mature or immature lobules.
To expand upon this idea, we further examined the
hierarchal complexity by generating SPADE trees indi-
vidually from Type I/Type II and Type III epithelial cells
(Figure 6D, E; Additional file 1: Figure S2B, C). Following
SPADE, we examined the colored trees to manually iden-
tify the ML, LPC, MB or BPC populations represented
by each part of the tree (Additional file 1: Figure S2B, C).
Interestingly, epithelial cells within the Type III lobules
demonstrated a hierarchal tree of increased complexity
compared to the tree formed by epithelial cells of Type I/
Type II lobules (Figure 6D, E; Additional file 1: Figure
S2B, C). Compared to Type I/Type II lobules, the epithe-
lial hierarchy of the Type III lobules demonstrated mul-
tiple branches with smaller nodes, suggesting the presence
of rare epithelial populations that cluster together
(Figure 6E). These results suggest that with increasing
glandular maturity, the epithelial hierarchy also becomes
more complex.
Discussion
The human breast undergoes extensive remodeling fol-
lowing birth through pregnancy and lactation, suggesting
the presence of a cellular hierarchy to functionally
expand the epithelium. Here, we demonstrate that alveo-
lar and ductal structural progenitors exist and reside
within luminal and basal lineages of the breast, respect-
ively. Our findings strongly support a model of the
breast epithelial hierarchy in which two types of pheno-
typically distinguishable progenitors contribute to spe-
cific structural elements of the mammary tree (ducts or
alveoli) and that the combination of these progenitor cell
populations is necessary for development and mainten-
ance of mammary tissues. Luminal alveolar progenitors
are more abundant in transplant assays and in vitro colla-
gen assays than basal ductal progenitors, and SPADE
demonstrated that the luminal lineages show increasing
complexity with lobule maturity. These results suggest
that different types of luminal alveolar progenitors may
exist within the breast to functionally expand the lobules.
Stem/progenitor cells have been an important area of
investigation for understanding the cellular origin of
breast cancer (for review, [2]). Localization of stem/pro-
genitor cells within human tissue has been challenging
due to limitations on tissue availability, patient hetero-
geneity, and differences among techniques to measure
stem/progenitor activity and cell surface markers used in
studies. Multiple studies have examined stem/progenitor
activity in populations defined by cell surface markers
[11,16,20,22,30,31], but have reported conflicting results
about whether luminal or basal lineages were enriched
for progenitor activity. Here, we show the relationships
among the assays used to detect stem/progenitor activ-
ity, as well as their relationships with the cell surface
markers most commonly used. Although there are im-
portant functional differences among the lineages, both
the luminal and basal lineages retain distinct progenitor
competency. Further, we show that Type I lobules, which
are the least developed of the breast lobules and most
closely associated with terminal ducts, are enriched in
progenitor activity. Although we did not directly assess
collecting ducts, our results are consistent with those
found by Villadsen and colleagues who previously mapped
progenitor activity to cells within main and terminal
ducts, through use of collagenase digestion of breast
epithelial organoids and microdissection [22].
Recent studies of the mouse epithelial hierarchy have in-
corporated numerous cell surface markers to characterize
specific epithelial populations. However, determining the
relationships among the cells identified by these markers
has proven challenging. For the first time, using SPADE
we identified specific differences between breasts enriched
for Type I/Type II and Type III lobules that were ob-
scured by traditional flow cytometry gating. Epithelial cells
isolated from tissues enriched for Type I/Type II lobules
demonstrated increases in basal lineages and mammary
lineage negative cells, as well as different clusters of LPCs,
compared with those from Type III lobules. Additionally,
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http://breast-cancer-research.com/content/16/5/453epithelial cells enriched from Type III lobules demon-
strated increased clusters of mature luminal cells, which
clustered into a more complex hierarchy when examined
individually. Although recent studies have begun the inte-
gration of more cell surface markers to delineate the spe-
cific functions of different luminal epithelial cell types
[30], the relationship between different luminal progenitor
cells and lobule types were not examined. Identification
and localization of these cell types in the context of lobule
maturity may clarify functional studies of breast epithelial
cells, where inherent breast heterogeneity often obscures
consistent results.
Lineage tracing to physiologically identify and characterize
progenitor cells in the mouse mammary gland has demon-
strated that following birth, the expansion and mainten-
ance of the luminal and basal lineages is ensured by the
presence of lineage-restricted progenitor cells [9,32].
Elegant studies have demonstrated that expression of both
CK14 and CK8 were restricted to basal and luminal cells,
respectively [9]. However, within human breast tissue, the
presence of CK14
+ epithelial cells within the luminal layer
have been previously described [33-36], although the
localization of CK14
+ luminal cells was not evaluated with
respect to lobule types. Here, we show that expression of
CK8 and CK14 was variable in Type I lobules, with lu-
minal expression of CK14 and basal expression of CK8 as
well as co-expression of both cytokeratins in the luminal
and basal layers. These results suggest that either human
epithelial cell lineages are not as restricted as in the mur-
ine gland, or that CK8 and 14 expression is less specific
to the luminal and basal lineages in the human as it is in
the mouse. Although CK14 was present in luminal cells
in Type I lobules, we did not identify any p63
+ epithelial
cells in this layer, suggesting that CK14 may not always
be a precise marker for basal epithelial cells.
Russo and Russo have classified the degree of breast
complexity into Type I, Type II, and Type III lobules
[6-8]. The increasing lobular complexity during pregnancy
in preparation for lactation suggests that the lobules be-
come successively more mature in the progression from
T y p eIt oT y p eI I I .T h i si m p l i e st h a tb r e a s tt i s s u ef r o m
multiparous women contain an increased number of Type
III lobules compared to the breasts of nulliparous women.
Although mice undergo complete involution following
pregnancy, resulting in parous mammary glands that
are structurally very similar to nulliparous glands, the
degree of involution in humans following pregnancy
has not been well-characterized. Additionally, Type III
lobules have been identified in very young nulliparous
breast tissue [37,38], which suggests that considerable
heterogeneity exists among all patient samples, regardless
of parity. Interestingly, in breast tissue from women
undergoing elective reduction mammoplasty surgery,
we observed surprising variability among lobules of the
same patient for steroid receptor expression and prolifera-
tion, suggesting an underlying mechanism of regulation
for lobule expansion. Even under the differentiating condi-
tions of pregnancy, studies have noted that it is not un-
usual to see acini that are devoid of proliferative markers,
while other acini demonstratead r a m a t i cp r o l i f e r a t i v e
response [37,38]. Clearly, the mechanisms regulating the
response of individual lobule types to hormonal stimuli re-
quire further investigation to determine why one lobule
may remain quiescent, while others expand.
In this study, we did not observe any clear differences
between Type I, II, and III lobules and age or parity,
however, the number of patients examined in this study
was small. Although we tried to obtain detailed repro-
ductive information about the patients used in this
study, we were not able to obtain information regarding
the phase of the menstrual cycle or phase of oral contra-
ceptive use at the time of surgery. Given the critical role
that steroid hormones play in breast development [3,6],
changes circulating levels of progesterone and estrogen
during the course of the menstrual cycle may influence
the complexity of the epithelial populations present within
the mammary gland as well as the structures of the lob-
ules. A large study conducted with detailed questionnaires
in addition to quantification of breast lobule types and
epithelial cell surface markers would need to be conducted
in order to fully address this issue.
Type I lobules have been characterized as being the least
mature of the lobules types of the breast [6,8]. Our results
support this hypothesis, given the heterogeneity of expres-
sion of multiple markers within this lobule type. Interest-
ingly, a recent study has demonstrated that breast tissue
of aging women shows an increase in luminal CK14 ex-
pression [39], however, the localization of these cells was
not directly examined within the lobules. Following meno-
pause, the breast undergoes involution [40], which may in-
crease the number of Type I lobules present within the
tissue. Given that women older than 50 years account for
the majority of new breast cancer diagnoses [40], examin-
ing the effect of aging on lobule composition may provide
insight into the origin of breast cancer in this population.
Studies examining the effects of carcinogens on tumori-
genesis using rodent models have supported the idea that
transformation of cells in Type I lobules give rise to the
most common breast malignancies, whereas dysregulated
growth in more mature lobules become benign breast le-
sions [41,42]. However, a nested case-control study in the
Nurses’ Health Studies demonstrated that women with
predominantly Type I lobules within their breast had a de-
creased risk of breast cancer compared with those who
had no Type I lobules or mixed lobule types [43]. Unravel-
ing the normal growth regulation of specific lobules within
the breast may provide insight into the dysregulated growth
during cancer. As our data suggest underlying differences
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http://breast-cancer-research.com/content/16/5/453in the epithelial hierarchy between breasts with immature
and mature lobules, studies examining the correlation
between the lobule types present in the normal tissue
matched with the specific breast tumor subtype could
potentially clarify the differences between rodent and
human models of breast cancer.
Conclusions
In this study, we characterized progenitor cell activity in
human breast tissue and identified the relationships among
different assays to detect stem cells within the human epi-
thelial hierarchy. Further, we elucidated the structural and
anatomical location of undifferentiated progenitor cells
within the breast lobules and identified specific differences
in the cellular hierarchy that exist between tissues pre-
dominantly consisting of mature or immature lobules.
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